CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
CVI Accepts, published online ahead of print on 12 December 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
CVI.00334-07v1
15/2/227    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yakes, B. J.
Right arrow Articles by Porter, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yakes, B. J.
Right arrow Articles by Porter, M. D.

 Previous Article  |  Next Article 

Clin. Vaccine Immunol. doi:10.1128/CVI.00334-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Detection of Mycobacterium avium subsp. paratuberculosis using Surface-Enhanced Raman Scattering: Part I – Sonicate Immunoassay

Betsy Jean Yakes, Robert J. Lipert, John P. Bannantine, and Marc D. Porter*

Departments of Chemistry and Chemical and Biological Engineering, Ames Laboratory-USDOE, and Institute for Combinatorial Discovery, Iowa State University, Ames, IA 50011; USDA/ARS/National Animal Disease Center, Bacterial Diseases of Livestock Research Unit, Ames, IA 50010

* To whom correspondence should be addressed. Email: marc.porter{at}utah.edu.


   Abstract

A sandwich immunoassay is developed for the rapid, low-level detection of Mycobacterium avium subsp. paratuberculosis (MAP). MAP is the causative agent of Johne's disease in cattle, and one of the major obstacles in controlling the spread of this disease is the inability to rapidly detect small amounts of bacteria or other diagnostic markers shed during the subclinical stage of infection. This paper details the development and performance of an assay for sonicated MAP lysate that is based on surface-enhanced Raman scattering (SERS). There are two key components of the assay: (1) an immobilized layer of monoclonal antibodies that target a surface protein on the microorganism; and (2) extrinsic Raman labels (ERLs) that are designed to selectively bind to captured proteins and produce large SERS signals. By correlating the number of MAP bacilli present prior to sonication and the amount of total protein in the resulting sonicate, the detection limit determined for total protein can be translated to the microorganism concentration. These findings yield detection limits of 100 and 200 ng/mL (estimated at 500 and 1000 MAP/ml) for sonicate spiked in phosphate buffer and in whole milk, respectively. Moreover, the time required to complete the assay, which includes sample preparation, antigen extraction, ERL incubation, and read out, is less than 24 h. The potential for incorporation of this novel assay into diagnostic laboratories is also briefly discussed.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.